Latest News about NPCE
Recent news which mentions NPCE
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
From Benzinga
NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript
August 12, 2022
Tickers
NPCE
From Motley Fool
Earnings Scheduled For August 11, 2022
August 11, 2022
From Benzinga
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
From Benzinga
Tickers
NPCE
From Motley Fool
From Benzinga
NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript
March 10, 2022
Tickers
NPCE
From Motley Fool
Earnings Scheduled For March 10, 2022
March 10, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 02, 2022
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
50 Biggest Movers From Yesterday
November 30, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
From Benzinga
NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
November 11, 2021
Tickers
NPCE
From Motley Fool
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
NeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript
August 13, 2021
Tickers
NPCE
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.